CTOR – citius oncology, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CTOR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

9/23

08:46 am

ctor

Citius Oncology (NASDAQ:CTOR) was upgraded by analysts at Citigroup Inc. from a "hold" rating to a "buy" rating.

Medium Report

Citius Oncology (NASDAQ:CTOR) was upgraded by analysts at Citigroup Inc. from a "hold" rating to a "buy" rating.

Report

9/23

08:03 am

ctor

Citius Oncology (NASDAQ:CTOR) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $6.00 price target on the stock.

Low Report

Citius Oncology (NASDAQ:CTOR) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $6.00 price target on the stock.

Report

9/23

07:45 am

ctor

Rating for CTOR

Low Report

Rating for CTOR

Report

9/23

07:25 am

ctor

Citius Oncology upgraded to Buy from Hold at Maxim

Low Report

Citius Oncology upgraded to Buy from Hold at Maxim

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.